10.65
0.26 (2.50%)
| Penutupan Terdahulu | 10.39 |
| Jumlah Dagangan | 193,450 |
| Harga / Jualan (P/S) | 778.66 |
| Harga / Buku (P/B) | 4.91 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -42,029.54% |
| EPS Cair (TTM) | -29.16 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 557,150.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.82% |
| Nisbah Semasa (MRQ) | 0.210 |
| Aliran Tunai Operasi (OCF TTM) | -11.67 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -6.16 M |
| Pulangan Atas Aset (ROA TTM) | -85.55% |
| Pulangan Atas Ekuiti (ROE TTM) | -3,891.64% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Kazia Therapeutics Limited | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.71 |
|
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.09% |
| % Dimiliki oleh Institusi | 8.22% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |